Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Comment by Chuck03on Sep 10, 2017 3:54pm
113 Views
Post# 26677397

RE:RE:RE:RE:Reasons why I'm All-in... Yours?

RE:RE:RE:RE:Reasons why I'm All-in... Yours?
EATSavage wrote:

On Page 15 of their MD&A it says :

"Accordingly, as at May 31, 2017, management believes that the cash balance is sufficient to meet its general working capital requirements and contractual obligations for the short-term, however, to complete the subsequent phases of its clinical trials the Company will require additional long-term funding."

Was there a PP after May 31? Also, is there any revenue streams coming in (even if it's small)?

Again - i'm still new here and am poking through their NRs and MD&As.



I believe there is enough money for clinical trials for ppp001, and the funding necessary for the subsequent phases of clinical trials are with other products in the pipeline. Anyway, revenue should be starting any day now.
<< Previous
Bullboard Posts
Next >>